首页> 外文学位 >An improved layer-by-layer self-assembly technique to generate biointerfaces for platelet adhesion studies: Dynamic LbL.
【24h】

An improved layer-by-layer self-assembly technique to generate biointerfaces for platelet adhesion studies: Dynamic LbL.

机译:一种改进的逐层自组装技术,可产生用于血小板粘附研究的生物界面:动态LbL。

获取原文
获取原文并翻译 | 示例

摘要

Layer-by-layer self-assembly (LbL) is a technique that generates engineered nano-scale films, coatings, and particles. These nanoscale films have recently been used in multiple biomedical applications. Concurrently, microfabrication methods and advances in microfluidics are being developed and combined to create "Lab-on-a-Chip" technologies. The potential to perform complex biological assays in vitro as a first-line screening technique before moving on to animal models has made the concept of lab on a chip a valuable research tool.;Prior studies in the Biofluids Laboratory at Louisiana Tech have used layer-by-layer and in vitro biological assays to study thrombogenesis in a controlled, repeatable, engineered environment. The reliability of these previously established techniques was unsatisfactory for more complex cases such as chemical and shear stress interactions.;The work presented in this dissertation was performed to test the principal assumptions behind the established laboratory methodologies, suggest improvements where needed, and test the impact of these improvements on accuracy and repeatability.;The assumptions to be tested were: (1) The fluorescence microscopy (FM) images of acridine orange-tagged platelets accurately provide a measure of percent area of surface covered by platelets; (2) fibrinogen coatings can be accurately controlled, interact with platelets, and do not interfere with the ability to quantify platelet adhesion; and (3) the dependence of platelet adhesion on chemical agents, as measured with the modified methods, generally agrees with results obtained from our previous methods and with known responses of platelets that have been documented in the literature.;The distribution of fibrinogen on the final LbL surface generated with the standard, static process (s-LbL) was imaged by tagging the fibrinogen with an anti-fibrinogen antibody bound to fluorescein isothiocyanate (FITC). FITC FM images and acridine orange FM images were taken sequentially at selected surface locations to generate a composite overlap of presumed platelet adhesion as a function of fibrinogen distribution. The method was unable to distinguish the surface from the adhered cells. The surface inhomogeneity and porosity retained a large amount of acridine orange stain, even in the absence of platelets, and components in the platelet-rich plasma (PRP) were found to fix acridine orange in a mode that fluoresced in the FITC imaging FM. Both of these problems obfuscated the platelet adhesion FM results when using s-LbL surfaces and acridine orange staining of platelets.;A dynamic process (d-LbL) was developed in which a solution of the molecule to be layered was constantly washed over the surface, and was constantly mixed to maintain a more homogeneous distribution of solute relative to the surface during the layering process. The d-LbL surfaces were tested as described above, and found to reduce the size and number of regions of anomalous acridine orange pooling trapped by the surface, providing a greater consistency and reliability in identifying platelets.;The improved surface was then used in a series of platelet adhesion experiments under static and dynamic flow conditions, and with and without the chemical additive L-arginine. The complex microcharmel system used in prior studies was replaced with a simpler system involving fewer nuisance variables for these tests.;The tests were performed on both collagen and fibrinogen surfaces. Collagen has been used as a thrombogenic surface in multiple studies in the literature, but produces additional variables in thrombogenesis control that are avoided when fibrinogen is used. In these tests, fibrinogen was found to be as thrombogenic as collagen, and platelet coverage of both biointerfaces was reduced by L-arginine in a manner similar to previously reported work.;The simpler system differed from the previous microchannel system in important factors: (1) It exposed the platelets to much lower shear stresses; (2) It introduced an oscillatory flow, which introduced a higher degree of variability in the adhesion than previously reported; (3) the previous work had not removed the acridine orange surface problems. Therefore, a direct comparison between results was not possible.;The new d-LbL surface process was successful in testing the basic assumptions. Testing showed that the new process eliminated the anomalous acridine orange retention problem during fluorescence imaging. This improvement in fluorescence response meant that the FM results matched the platelet adhesion on plain glass slides and adhesion reported by others in microfluidic flows. The chemical additive responses behaved as expected, with an increase in L-arginine contributing to a decrease in thrombogenesis under dynamic conditions, but not under static conditions.
机译:逐层自组装(LbL)是一种产生工程化的纳米级薄膜,涂层和颗粒的技术。这些纳米级薄膜最近已用于多种生物医学应用中。同时,微制造方法和微流体技术的进步正在发展并结合起来,以创建“芯片实验室”技术。在转为动物模型之前,作为一线筛选技术可以在体外进行复杂的生物学测定的潜力使片上实验室的概念成为一种有价值的研究工具。;路易斯安那理工大学生物流体实验室的先前研究已使用了层和体外生物学测定法研究可控,可重复,工程化环境中的血栓形成。这些先前建立的技术的可靠性在化学和剪切应力相互作用等较复杂的情况下并不令人满意。本论文中的工作是为了检验已建立的实验室方法背后的主要假设,在需要的地方提出改进建议,并测试其影响。 (1)cr啶橙标记的血小板的荧光显微镜(FM)图像可准确测量血小板覆盖的表面积百分比; (2)可以精确控制纤维蛋白原涂层,与血小板相互作用,并且不干扰量化血小板粘附的能力; (3)用改良方法测得的血小板粘附对化学药物的依赖性,通常与我们以前的方法所获得的结果以及文献中已记录的血小板的已知反应相吻合。通过用与异硫氰酸荧光素(FITC)结合的抗纤维蛋白原抗体标记纤维蛋白原,对通过标准静态过程(s-LbL)生成的最终LbL表面成像。在选定的表面位置顺序拍摄FITC FM图像和sequentially啶橙FM图像,以生成假定的血小板粘附力随纤维蛋白原分布而变化的复合重叠。该方法无法从粘附细胞中分辨出表面。即使在没有血小板的情况下,表面的不均匀性和孔隙率也保留了大量的cr啶橙染色,并且发现富含血小板的血浆(PRP)中的组分以FITC成像FM发出荧光的方式固定了cr啶橙。当使用s-LbL表面和a啶橙染色时,这两个问题都混淆了血小板粘附FM结果。;开发了一种动态过程(d-LbL),其中要分层的分子溶液不断在表面上被冲洗并在成层过程中不断混合以保持溶质相对于表面的更均匀分布。如上所述对d-LbL表面进行了测试,发现可以减少表面捕获的异常a啶橙汇集池的大小和区域数量,从而在识别血小板方面提供更大的一致性和可靠性。在有和没有化学添加剂L-精氨酸的静态和动态流动条件下进行的一系列血小板粘附实验。以前的研究中使用的复杂的微炭素系统被一个较简单的系统所取代,该系统涉及的滋扰变量较少。这些测试是在胶原蛋白和纤维蛋白原表面上进行的。胶原蛋白已在许多研究中用作血栓形成表面,但在血栓形成控制中会产生其他变量,使用纤维蛋白原可避免这些变量。在这些测试中,发现纤维蛋白原与胶原蛋白一样具有血栓形成性,并且L-精氨酸以与先前报道的工作类似的方式降低了两个生物界面的血小板覆盖率。;更简单的系统在重要因素上与先前的微通道系统不同: 1)将血小板暴露在低得多的剪切应力下; (2)它引入了振荡流,从而导致了比以前报道的粘连程度更高的变化; (3)以前的工作并未消除removed啶橙表面的问题。因此,不可能直接比较结果。新的d-LbL表面工艺成功地测试了基本假设。测试表明,新工艺消除了荧光成像过程中a啶橙的异常保留现象。荧光响应的改善意味着FM结果与普通玻璃载玻片上的血小板粘附性以及其他微流中报道的粘附性相匹配。化学加成反应的行为符合预期,在动态条件下(而非静态条件下),L-精氨酸的增加有助于血栓形成的减少。

著录项

  • 作者

    Lopez, Juan Manuel.;

  • 作者单位

    Louisiana Tech University.;

  • 授予单位 Louisiana Tech University.;
  • 学科 Engineering Biomedical.;Nanoscience.;Nanotechnology.
  • 学位 Ph.D.
  • 年度 2010
  • 页码 192 p.
  • 总页数 192
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号